5 Actionable Lessons Learned from the RADx Initiative by NIH

Global Medical Device Podcast · 27 Jan 2021 · 47m · Episode 177

What this episode covers

Devon Campbell, founder of Prodct, joins Jon Speer of Greenlight Guru to share five lessons from the NIH's RADx initiative, which accelerated COVID-19 diagnostic development. Campbell explains how early-stage startups can maintain speed and regulatory compliance by documenting protocols immediately, implementing lean design controls, and leveraging technical advisory boards. The discussion emphasizes starting with the end in mind to manage risk and avoid the inertia that often slows down established medical device companies.

Other shows on the same ground, closest first.

  • Being an Engineer · 51m

    S1E13 A Holistic View on Product Development | Devon Campbell

    Devon Campbell, founder of Prodct LLC, discusses his advisory practice for early-stage biotech and medical device companies, drawing on his experience at Ventana Medical Systems, Quanterix, and Novartis. He explains how his background in machine shop operations and holistic product development—from design to field service—enabled his rapid rise to senior leadership roles. Campbell advocates for dual-career tracks in engineering, allowing brilliant technical contributors to become 'fellows' without becoming managers, and emphasizes the importance of integrating regulatory strategy (FDA, ISO 13485) from the earliest stages of product development to avoid costly rework.

  • The Pragmatic Embedded Podcast · 33m

    Lean and Agile at a Product Development Consultancy

    Jose Borquez, CEO of Bold Type, a product development consultancy specializing in connected wireless medical devices, explains how his firm integrates Lean and Agile methodologies into hardware and regulatory-heavy workflows. He details the use of formative usability studies, iterative sprints that include documentation updates, and the strategic advantage of over-the-air firmware updates for post-launch improvements. Borquez also discusses the challenges of managing client bureaucracy and the importance of rapid, transparent communication to maintain trust and speed.

  • Let's Combinate · 1h 07m

    017 - "Feet First" with Ahmed Zobi

    Ahmed Zobi, Founder and CEO of Syntr Health Technologies, explains how he bootstrapped his company from a university project to FDA 510(k) clearance for the SyntrFuge System, a device that automates the microsizing of adipose tissue for body contouring and wound care. Zobi details the strategic decision to target aesthetics and orthopedics first to generate revenue while pursuing diabetic foot ulcer indications, and describes the intense personal sacrifices made during the grant submission process and the COVID-19 pandemic. He emphasizes the importance of leveraging mentors, conducting customer discovery through the NSF iCorps program, and building a robust quality management system early to navigate regulatory requirements.

  • Let's Combinate · 37m

    154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell

    Devon Campbell, Founder of Prodct LLC and CPO of myBiometry, explains the regulatory and engineering distinctions between In Vitro Diagnostics (IVDs), Lab Developed Tests (LDTs), and companion diagnostics. He details how IVD development mirrors medical device design control but adds critical layers of risk management regarding false positives and negatives, particularly for home-use devices like COVID tests. Campbell emphasizes that clinical validation requires proving statistical validity across diverse populations to establish Limit of Detection (LOD) and sensitivity, noting that clinical studies are often the most time-consuming and expensive part of the process for startups.

  • Being an Engineer · 53m

    S7E19 Ryan Schoonmaker | How to Take A Structured Approach to Solving Engineering Problems

    Ryan Schoonmaker, founder of Tight Line Solutions and former Director of Mechanical Engineering at Beta Bionics, Dexcom, and BD, explains how to bring structure to chaotic product development. He emphasizes that successful execution requires clear requirements, robust assembly specifications, and early decisions on critical elements like component colors to avoid regulatory delays. Schoonmaker draws on his experience with the Dexcom G6 and G7 to illustrate how narrowing down system failures and managing technical debt differently at startups versus large enterprises leads to predictable outcomes.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.